Close Menu

Fool Me Once…

In The Scientist PNNL's Steven Wiley explains why he's sat out the mad rush for Challenge Grants. "Although the intent is good, history suggests that these grants will eventually be looked upon as one of the greatest time wasters of the decade," he writes. In the '90s, he says there was a similar rush for funding from the US Army Breast Cancer Research Program and for that his area of research was only funded at four percent -- "much less than the NIH payline."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.